Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Results from human pharmacokinetic studies support once-daily dosing for MK-991

Oct. 1, 1998

MEN-10700 highly active against pneumococci, gonococci and meningococci

Oct. 1, 1998

Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D

Oct. 1, 1998

Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC

Oct. 1, 1998

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Bayer and Novalon enter collaborative agreement to discover antiinfective drugs

Oct. 1, 1998

Potent, broad-spectrum, orally active 2-pyridone antibacterial enters Abbott pipeline

Sep. 30, 1998

Valaciclovir therapy suppresses viral shedding in patients with genital herpes

Sep. 30, 1998

SB initiates phase III trials with fluoroquinolone antibiotic

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...